ArticleScientific reports2026
A deep-SVM hybrid framework with enhanced EEG feature engineering and SHAP-based explainability for Alzheimer's classification.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Knowledge-Guided Deep Learning with Clinical EEG Biomarkers for Automated Dementia Detection and Staging.Diagnostics (Basel, Switzerland) · 2026Article
- Explainable EEG-based machine learning for early diagnosis of Alzheimer's disease and frontotemporal dementia.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Accurate classification among Alzheimer's Disease (AD), Fronto Temporal Dementia (FTD), and Cognitively Normal (CN) adults from EEG remains challenging. We propose a multi-class classification method that fuses interpretable spectral/connectivity biomarkers (band power, spectral entropy, α-coherence) with compact temporal embeddings from a customized lightweight one Dimensional Convolutional Neural Network (1D-CNN). The fused features are reduced by Principal Component Analysis (PCA) and classified with Support Vector Machine (SVM). All data-dependent steps like Synthetic Minority Over Sampling Technique (SMOTE), z-scoring and PCA are fit strictly on training folds to prevent leakage. Hyperparameters including PCA dimensionality and SMOTE neighbors were selected via inner-loop grid sweeps that maximized macro-F1; full grids and class distributions before/after SMOTE (inner-train only) are reported in the Supplement. On OpenNeuro ds004504 (eyes-closed; [Formula: see text]; 36 AD/23 FTD/29 CN) the model achieved 94.5% accuracy, macro-F1 [Formula: see text], and AUC [Formula: see text]. Robustness was examined on two public datasets using the identical preprocessing/segmentation: (i) cross-condition testing on ds006036 (eyes-open recordings from the same participants) and (ii) zero-shot transfer to an independent OSF dataset with different instrumentation and demographics. SHapley Additive exPlanations (SHAP) analyses provided global, class-wise, and subject-level attributions aligned with known electrophysiology (e.g., reduced α-coherence, elevated θ), supporting clinical interpretability. These results indicate that a transparent hybrid feature design can deliver accurate, leakage-safe, and explainable EEG-based differentiation of AD, FTD, and CN with preliminary external checks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.